Literature DB >> 20649663

Fatigue after myocardial infarction: relationships with indices of emotional distress, and sociodemographic and clinical variables.

Pia Alsén1, Eva Brink, Yvonne Brändström, Björn W Karlson, Lars-Olof Persson.   

Abstract

Fatigue and depressive symptoms are relatively common among patients recovering from myocardial infarction (MI). The symptoms of depression and fatigue overlap. The present study aimed at identifying patient fatigue and at examining the incidence of fatigue, particularly without coexisting depression, after MI. The sample comprised 204 consecutive patients who had completed the questionnaires Hospital Anxiety and Depression Scale and the Multidimensional Fatigue Inventory-20 after MI (1 week and 4 months). The results showed that fatigue had decreased after 4 months compared with the time of MI onset. Compared with the general population, patients reported significantly higher levels of fatigue. Furthermore, fatigue was associated with depression, but 33% of the sample reported fatigue without coexisting depression after 4 months. In order to prevent or treat patients' symptoms of fatigue after MI, the concepts of fatigue and depression should be assessed separately so as to exclude overlapping effects.

Entities:  

Mesh:

Year:  2010        PMID: 20649663     DOI: 10.1111/j.1440-172X.2010.01848.x

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  10 in total

1.  Self-management Following a Cardiac Event in People of Chinese Ethnicity Living in Western Countries: A Scoping Review.

Authors:  Ling Zhang; Robyn Gallagher; Ding Ding; Lis Neubeck
Journal:  J Immigr Minor Health       Date:  2018-06

2.  Comparing comorbidity measures and fatigue post myocardial infarction.

Authors:  Carolyn E Horne; Sharona Johnson; Patricia B Crane
Journal:  Appl Nurs Res       Date:  2018-11-07       Impact factor: 2.257

3.  A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders.

Authors:  Lena Hedlund; Amanda Lundvik Gyllensten; Lars Hansson
Journal:  Community Ment Health J       Date:  2014-06-28

4.  Fatigue two months after myocardial infarction and its relationships with other concurrent symptoms, sleep quality and coping strategies.

Authors:  Ulla Fredriksson-Larsson; Pia Alsén; Björn W Karlson; Eva Brink
Journal:  J Clin Nurs       Date:  2015-05-19       Impact factor: 3.036

5.  Factors in relation with fatigue and illness perception in patients with myocardial infarction and the changes in fatigue due to intervention on illness perception: Research design, methodology, and preliminary results.

Authors:  Reza Bagherian-Sararoudi; Mohammadreza Maracy; Hamid Sanei; Mansoor Shiri
Journal:  ARYA Atheroscler       Date:  2019-03

Review 6.  Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions.

Authors:  Ruel Billones; Josephine K Liwang; Kierra Butler; Letitia Graves; Leorey N Saligan
Journal:  Brain Behav Immun Health       Date:  2021-05-21

7.  Considering both health-promoting and illness-related factors in assessment of health-related quality of life after myocardial infarction.

Authors:  Eva Brink
Journal:  Open Nurs J       Date:  2012-08-30

8.  I've lost the person I used to be--experiences of the consequences of fatigue following myocardial infarction.

Authors:  Ulla Fredriksson-Larsson; Pia Alsen; Eva Brink
Journal:  Int J Qual Stud Health Well-being       Date:  2013-06-14

9.  Fatigue in Older Adults Postmyocardial Infarction.

Authors:  Patricia Barton Crane; Jimmy T Efird; Willie Mae Abel
Journal:  Front Public Health       Date:  2016-04-11

10.  Validation of the Multidimensional Fatigue Inventory with Coronary Artery Disease Patients.

Authors:  Julija Gecaite-Stonciene; Adomas Bunevicius; Julius Burkauskas; Julija Brozaitiene; Julius Neverauskas; Narseta Mickuviene; Nijole Kazukauskiene
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.